Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 | +$574M | |
| 2 | +$573M | |
| 3 | +$446M | |
| 4 |
Micron Technology
MU
|
+$389M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$387M |
Top Sells
| 1 | +$1.19B | |
| 2 | +$1.11B | |
| 3 | +$557M | |
| 4 |
Autodesk
ADSK
|
+$554M |
| 5 |
RNAM
Avidity Biosciences
RNAM
|
+$490M |
Sector Composition
| 1 | Technology | 34.83% |
| 2 | Healthcare | 19.29% |
| 3 | Consumer Discretionary | 9.89% |
| 4 | Financials | 9.74% |
| 5 | Industrials | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
TFI International
TFII
$9.11B
| $391M | 0.18% |
3,780,501
+9,121
|
|
||
127
United Therapeutics
UTHR
$23.2B
| $388M | 0.17% |
796,101
+341,383
|
|
||
128
ServiceNow
NOW
$128B
| $386M | 0.17% |
2,518,061
-1,916,229
|
|
||
129
Union Pacific
UNP
$150B
| $384M | 0.17% |
1,658,731
+272,429
|
|
||
130
Lantheus
LNTH
$5.31B
| $380M | 0.17% |
5,707,247
-977,490
|
|
||
131
Steris
STE
$22.3B
| $376M | 0.17% |
1,482,635
+13,175
|
|
||
132
PTC Therapeutics
PTCT
$5.66B
| $369M | 0.17% |
4,851,332
+1,077,776
|
|
||
133
ICU Medical
ICUI
$3.29B
| $368M | 0.16% |
2,576,756
+103,220
|
|
||
134
Wayfair
W
$9.9B
| $359M | 0.16% |
3,570,475
+166,855
|
|
||
135
Structure Therapeutics
GPCR
$4B
| $354M | 0.16% |
5,090,148
+641,322
|
|
||
136
Moody's
MCO
$82B
| $345M | 0.15% |
675,076
+260,431
|
|
||
137
HubSpot
HUBS
$15.1B
| $344M | 0.15% |
863,817
-283,247
|
|
||
138
Sensata Technologies
ST
$4.82B
| $343M | 0.15% |
10,289,698
+230,113
|
|
||
139
Glaukos
GKOS
$6.14B
| $341M | 0.15% |
3,018,787
+1,953,578
|
|
||
140
Flutter Entertainment
FLUT
$19.2B
| $340M | 0.15% |
1,580,795
+168,724
|
|
||
141
Cboe Global Markets
CBOE
$31.3B
| $337M | 0.15% |
1,341,809
-31,356
|
|
||
142
iShares Core US Aggregate Bond ETF
AGG
$140B
| $335M | 0.15% |
3,355,397
+218,063
|
|
||
143
Dell
DELL
$97.1B
| $334M | 0.15% |
2,654,062
+561,401
|
|
||
144
Schwab US Large- Cap ETF
SCHX
$63.4B
| $334M | 0.15% |
12,410,720
+983,108
|
|
||
145
Costco
COST
$446B
| $333M | 0.15% |
386,163
|
|
||
146
Soleno Therapeutics
SLNO
$2.14B
| $332M | 0.15% |
7,178,354
+1,122,015
|
|
||
|
SARO
147
StandardAero Inc
SARO
$9.51B
| $322M | 0.14% |
11,224,061
+1,108,066
|
|
||
148
UBS Group
UBS
$119B
| $320M | 0.14% |
6,861,746
+4,919,494
|
|
||
149
Novartis
NVS
$311B
| $308M | 0.14% |
2,234,418
+165,692
|
|
||
150
Analog Devices
ADI
$156B
| $306M | 0.14% |
1,127,271
-76,247
|
|